Nac (Acetylcysteine)

Acetylcysteine works by breaking disulfide bonds in mucus glycoproteins, which reduces the thickness and stickiness of the mucus. This facilitates mucociliary clearance and also replenishes intracellular glutathione, supporting antioxidant defenses in the respiratory epithelium.

The dose of Nac is determined by the prescribing healthcare professional based on the patient’s condition, age, and renal function. The prescriber will specify the appropriate strength, frequency and duration of therapy on the prescription label.

Safety data for acetylcysteine in pregnancy are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit justifies any possible risk to the fetus. Breastfeeding mothers should consult their physician, as small amounts may be excreted in milk.

To order Nac, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Nac (acetylcysteine) differs from alternatives such as carbocisteine or bromhexine by directly cleaving disulfide bonds in mucus, providing a rapid reduction in viscosity. Carbocisteine works mainly by stimulating serous secretion, while bromhexine enhances ciliary activity. Choice of agent depends on clinical response, tolerability and physician preference.

Nac should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Nac is administered orally, typically as a tablet, capsule or liquid preparation. The patient should swallow the dose with a full glass of water unless otherwise directed by the prescriber. Administration should follow the dosing schedule indicated on the prescription.

The most serious adverse reactions to watch for include anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, bronchospasm, hepatic dysfunction and hemolysis in patients with G6PD deficiency. Any signs of these conditions require immediate medical attention and discontinuation of the product.

Nac should be avoided in individuals with a known hypersensitivity to acetylcysteine or any of the product’s excipients. Patients with active bronchospasm, severe asthma or a history of severe allergic reactions should use the drug only under close medical supervision.